U.S. Court of Appeals for the Federal Circuit, 2012

Otsuka Pharmaceutical Co., Ltd. v. Sandoz, Inc.

Otsuka Pharmaceutical Co., Ltd. v. Sandoz, Inc.
U.S. Court of Appeals for the Federal Circuit · Decided June 13, 2012

Otsuka Pharmaceutical Co., Ltd. v. Sandoz, Inc.

Opinion

United States Court of Appeals for the Federal Circuit ______________________ June 13, 2012 ERRATUM ______________________ Appeal Nos. 2011-1126, -1127 OTSUKA PHARMACEUTICAL CO., LTD., Plaintiff-Appellee, v. SANDOZ, INC., SUN PHARMACEUTICAL INDUSTRIES, LTD., SYNTHON BV, SYNTHON HOLDINGS BV, SYNTHON LABORATORIES, INC., and SYNTHON PHARMACEUTICALS, INC., Defendants, and APOTEX INC. and APOTEX CORP., Defendants-Appellants, and TEVA PHARMACEUTICALS USA, INC., BARR LABORATORIES, INC., and BARR PHARMACEUTICALS, INC., Defendants-Appellants.

Decided: May 7, 2012 Precedential Opinion ______________________ The following change has been made: Page 21, line 4, “marketed” has been changed to -- promising--.

Case-law data current through December 31, 2025. Source: CourtListener bulk data.